Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

EPRS Antikörper (AA 1207-1399)

EPRS Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7145566
  • Target Alle EPRS Antikörper anzeigen
    EPRS (Glutamyl-Prolyl-tRNA Synthetase (EPRS))
    Bindungsspezifität
    • 15
    • 7
    • 7
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1207-1399
    Reaktivität
    • 49
    • 36
    • 25
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 50
    Kaninchen
    Klonalität
    • 50
    Polyklonal
    Konjugat
    • 18
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser EPRS Antikörper ist unkonjugiert
    Applikation
    • 30
    • 13
    • 13
    • 8
    • 8
    • 7
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
    Kreuzreaktivität
    Human
    Aufreinigung
    >95%, Protein G purified
    Immunogen
    Recombinant Human Bifunctional glutamate/proline--tRNA ligase protein (1207-1399AA)
    Isotyp
    IgG
  • Applikationshinweise
    Recommended dilution: WB:1:500-1:5000, IHC:1:500-1:1000, IF:1:50-1:200,
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target
    EPRS (Glutamyl-Prolyl-tRNA Synthetase (EPRS))
    Andere Bezeichnung
    EPRS (EPRS Produkte)
    Synonyme
    EARS antikoerper, GLUPRORS antikoerper, PARS antikoerper, QARS antikoerper, QPRS antikoerper, wu:fb38d08 antikoerper, wu:ft34d10 antikoerper, 2410081F06Rik antikoerper, 3010002K18Rik antikoerper, C79379 antikoerper, Qprs antikoerper, glutamyl-prolyl-tRNA synthetase antikoerper, glutamyl-prolyl-tRNA synthetase S homeolog antikoerper, EPRS antikoerper, eprs antikoerper, eprs.S antikoerper, Eprs antikoerper
    Hintergrund

    Background: Catalyzes the attachment of the cognate amino acid to the corresponding tRNA in a two-step reaction: the amino acid is first activated by ATP to form a covalent intermediate with AMP and is then transferred to the acceptor end of the cognate tRNA. Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. Upon interferon-gamma activation and subsequent phosphorylation dissociates from the multisynthetase complex and assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3\\\'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation.

    Aliases: Bifunctional aminoacyl tRNA synthetase antibody, Bifunctional aminoacyl-tRNA synthetase antibody, Bifunctional glutamate/proline tRNA ligase antibody, Cell proliferation-inducing gene 32 protein antibody, DKFZp313B047 antibody, EARS antibody, Eprs antibody, GLNS antibody, Glu pro tRNA synthetase antibody, GLUPRORS antibody, GluRS antibody, Glutamate tRNA ligase antibody, Glutamatyl prolyl tRNA synthetase antibody, Glutaminyl tRNA synthetase antibody, Glutamyl prolyl tRNA synthetase antibody, Glutamyl tRNA synthetase antibody, Glutamyl-tRNA synthetase antibody, PARS antibody, PIG 32 antibody, PIG32 antibody, Proliferation inducing gene 32 protein antibody, Proliferation inducing protein 32 antibody, Proline tRNA ligase antibody, Proline--tRNA ligase antibody, Prolyl tRNA synthetase antibody, Prolyl-tRNA synthetase antibody, QARS antibody, QPRS antibody, SYEP_HUMAN antibody

    UniProt
    P07814
Sie sind hier: